The epidermal growth factor receptor (EGFR) is known to be highly expressed in non-small cell lung cancer, and studies have been conducted investigating nano-formulations with EGFR targeting ligands for the delivery of cisplatin to the cancer tissue following inhalation [80]. This evidence concerns the gene EGFR and cancer.